Stockholders' Equity	12 Months Ended
Mar. 31, 2020
Equity [Abstract]
Stockholders' Equity	Shareholders’ Equity Description of Capital Stock The Company has authorized share capital consisting of 750 million shares of common stock, par value $0.01 per share, and 1 million shares of preferred stock, par value $0.01 per share. Each share of common stock is equal in all respects to every other share of common stock of the Company. Each share of common stock is entitled to one vote per share at each annual or special meeting of shareholders for the election of directors and upon any other matter coming before such meeting. Subject to all the rights of the preferred stock, dividends may be paid to holders of common stock as and when declared by the Board of Directors. Cash Dividends During the fiscal year ended March 31, 2020, the Board of Directors declared cash dividends to our shareholders of approximately $39 million in the aggregate, of which approximately $30 million had been paid as of March 31, 2020 and approximately $10 million of which was paid on April 15, 2020. During the fiscal year ended March 31, 2019, the Board of Directors declared cash dividends to our shareholders of approximately $33 million in the aggregate, of which $25 million had been paid as of March 31, 2019 and $8 million of which was paid on April 16, 2019. On May 21, 2020, the Board of Directors declared a dividend of $0.07 per common share payable on July 15, 2020 to common shareholders of record at the close of business on June 11, 2020. Share Repurchase Program On June 1, 2018, the Board of Directors authorized up to $400 million for future repurchases of outstanding shares of Perspecta’s common stock. Repurchases may be made at the Company’s discretion from time to time on the open market depending on market conditions. The repurchase program has no time limit, does not obligate the Company to make any repurchases and may be suspended for periods or discontinued at any time. During the fiscal years ended March 31, 2020 and 2019, the Company repurchased 2.8 million and 2.7 million shares, respectively, of its common stock for aggregate consideration of $65 million and $60 million, respectively. The shares are reported as treasury shares at cost on the accompanying balance sheets. The total remaining authorization for future common share repurchases under the share repurchase program was $275 million as of March 31, 2020.

Shareholders’ Equity

Description of Capital Stock

The Company has authorized share capital consisting of 750 million shares of common stock, par value $0.01 per share, and 1 million shares of preferred stock, par value $0.01 per share.

Each share of common stock is equal in all respects to every other share of common stock of the Company. Each share of common stock is entitled to one vote per share at each annual or special meeting of shareholders for the election of directors and upon any other matter coming before such meeting. Subject to all the rights of the preferred stock, dividends may be paid to holders of common stock as and when declared by the Board of Directors.

Cash Dividends

During the fiscal year ended March 31, 2020, the Board of Directors declared cash dividends to our shareholders of approximately $39 million in the aggregate, of which approximately $30 million had been paid as of March 31, 2020 and approximately $10 million of which was paid on April 15, 2020. During the fiscal year ended March 31, 2019, the Board of Directors declared cash dividends to our shareholders of approximately $33 million in the aggregate, of which $25 million had been paid as of March 31, 2019 and $8 million of which was paid on April 16, 2019.

On May 21, 2020, the Board of Directors declared a dividend of $0.07 per common share payable on July 15, 2020 to common shareholders of record at the close of business on June 11, 2020.

Share Repurchase Program

On June 1, 2018, the Board of Directors authorized up to $400 million for future repurchases of outstanding shares of Perspecta’s common stock. Repurchases may be made at the Company’s discretion from time to time on the open market depending on market conditions. The repurchase program has no time limit, does not obligate the Company to make any repurchases and may be suspended for periods or discontinued at any time. During the fiscal years ended March 31, 2020 and 2019, the Company repurchased 2.8 million and 2.7 million shares, respectively, of its common stock for aggregate consideration of $65 million and $60 million, respectively. The shares are reported as treasury shares at cost on the accompanying balance sheets. The total remaining authorization for future common share repurchases under the share repurchase program was $275 million as of March 31, 2020.